$Singular Genomics (OMIC.US)$ Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share Monday, 23rd December at 8:30 am SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ: OMIC) ("Singular Genomics" or the "Company"), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement...
$Singular Genomics (OMIC.US)$ Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%), etc. SEC·
$Singular Genomics (OMIC.US)$ Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC ("Concentra") to acquire all o...
Singular Genomics Stock Forum
Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share
Monday, 23rd December at 8:30 am
SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ: OMIC) ("Singular Genomics" or the "Company"), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement...
📊⚡️📊
Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%), etc.
SEC·
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC ("Concentra") to acquire all o...
No comment yet